Service & Software
Global Microarray-based Non-Invasive Prenatal Testing Market Research Report 2026
- Mar 17, 26
- ID: 742752
- Pages: 119
- Figures: 118
- Views: 2
This report delivers a comprehensive overview of the global Microarray-based Non-Invasive Prenatal Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microarray-based Non-Invasive Prenatal Testing. The Microarray-based Non-Invasive Prenatal Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Microarray-based Non-Invasive Prenatal Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microarray-based Non-Invasive Prenatal Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Agilent Technologies
Ariosa Diagnostics (Roche)
BGI Group
Eurofins LifeCodexx GmbH
Illumina
Laboratory Corporation of America
Myriad Genetics
Natera
PerkinElmer Inc
Quest Diagnostics
Sequenom
Segment by Type
Trisomy Detection
Microdeletion Syndromes
Other
Segment by Application
Hospitals & Clinics
Independent Laboratories
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microarray-based Non-Invasive Prenatal Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Microarray-based Non-Invasive Prenatal Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Microarray-based Non-Invasive Prenatal Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Agilent Technologies
Ariosa Diagnostics (Roche)
BGI Group
Eurofins LifeCodexx GmbH
Illumina
Laboratory Corporation of America
Myriad Genetics
Natera
PerkinElmer Inc
Quest Diagnostics
Sequenom
Segment by Type
Trisomy Detection
Microdeletion Syndromes
Other
Segment by Application
Hospitals & Clinics
Independent Laboratories
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microarray-based Non-Invasive Prenatal Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Trisomy Detection
1.2.3 Microdeletion Syndromes
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microarray-based Non-Invasive Prenatal Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Independent Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Perspective (2021–2032)
2.2 Global Microarray-based Non-Invasive Prenatal Testing Growth Trends by Region
2.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Region (2021–2026)
2.2.3 Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (2027–2032)
2.3 Microarray-based Non-Invasive Prenatal Testing Market Dynamics
2.3.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends
2.3.2 Microarray-based Non-Invasive Prenatal Testing Market Drivers
2.3.3 Microarray-based Non-Invasive Prenatal Testing Market Challenges
2.3.4 Microarray-based Non-Invasive Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue
3.1.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue (2021–2026)
3.1.2 Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Microarray-based Non-Invasive Prenatal Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microarray-based Non-Invasive Prenatal Testing Revenue
3.4 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio
3.4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025
3.5 Global Key Players of Microarray-based Non-Invasive Prenatal Testing Head Offices and Areas Served
3.6 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications
3.7 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Type
4.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Type (2021–2026)
4.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (2027–2032)
5 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Application
5.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Application (2021–2026)
5.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
6.4 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
7.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
7.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
9.2 Latin America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
9.4 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Introduction
11.1.4 Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.1.5 Agilent Technologies Recent Development
11.2 Ariosa Diagnostics (Roche)
11.2.1 Ariosa Diagnostics (Roche) Company Details
11.2.2 Ariosa Diagnostics (Roche) Business Overview
11.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Introduction
11.2.4 Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.2.5 Ariosa Diagnostics (Roche) Recent Development
11.3 BGI Group
11.3.1 BGI Group Company Details
11.3.2 BGI Group Business Overview
11.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Introduction
11.3.4 BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.3.5 BGI Group Recent Development
11.4 Eurofins LifeCodexx GmbH
11.4.1 Eurofins LifeCodexx GmbH Company Details
11.4.2 Eurofins LifeCodexx GmbH Business Overview
11.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Introduction
11.4.4 Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.4.5 Eurofins LifeCodexx GmbH Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Introduction
11.5.4 Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.5.5 Illumina Recent Development
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Details
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Introduction
11.6.4 Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.6.5 Laboratory Corporation of America Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Introduction
11.7.4 Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.7.5 Myriad Genetics Recent Development
11.8 Natera
11.8.1 Natera Company Details
11.8.2 Natera Business Overview
11.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Introduction
11.8.4 Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.8.5 Natera Recent Development
11.9 PerkinElmer Inc
11.9.1 PerkinElmer Inc Company Details
11.9.2 PerkinElmer Inc Business Overview
11.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Introduction
11.9.4 PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.9.5 PerkinElmer Inc Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Introduction
11.10.4 Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.10.5 Quest Diagnostics Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Introduction
11.11.4 Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.11.5 Sequenom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Trisomy Detection
1.2.3 Microdeletion Syndromes
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microarray-based Non-Invasive Prenatal Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Independent Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Perspective (2021–2032)
2.2 Global Microarray-based Non-Invasive Prenatal Testing Growth Trends by Region
2.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Region (2021–2026)
2.2.3 Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (2027–2032)
2.3 Microarray-based Non-Invasive Prenatal Testing Market Dynamics
2.3.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends
2.3.2 Microarray-based Non-Invasive Prenatal Testing Market Drivers
2.3.3 Microarray-based Non-Invasive Prenatal Testing Market Challenges
2.3.4 Microarray-based Non-Invasive Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue
3.1.1 Global Top Microarray-based Non-Invasive Prenatal Testing Players by Revenue (2021–2026)
3.1.2 Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Microarray-based Non-Invasive Prenatal Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Microarray-based Non-Invasive Prenatal Testing Revenue
3.4 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio
3.4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025
3.5 Global Key Players of Microarray-based Non-Invasive Prenatal Testing Head Offices and Areas Served
3.6 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications
3.7 Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Type
4.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Type (2021–2026)
4.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (2027–2032)
5 Microarray-based Non-Invasive Prenatal Testing Breakdown Data by Application
5.1 Global Microarray-based Non-Invasive Prenatal Testing Historic Market Size by Application (2021–2026)
5.2 Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
6.2 North America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
6.4 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
7.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
7.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
8.2 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
9.2 Latin America Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
9.4 Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021–2032)
10.2 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Introduction
11.1.4 Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.1.5 Agilent Technologies Recent Development
11.2 Ariosa Diagnostics (Roche)
11.2.1 Ariosa Diagnostics (Roche) Company Details
11.2.2 Ariosa Diagnostics (Roche) Business Overview
11.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Introduction
11.2.4 Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.2.5 Ariosa Diagnostics (Roche) Recent Development
11.3 BGI Group
11.3.1 BGI Group Company Details
11.3.2 BGI Group Business Overview
11.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Introduction
11.3.4 BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.3.5 BGI Group Recent Development
11.4 Eurofins LifeCodexx GmbH
11.4.1 Eurofins LifeCodexx GmbH Company Details
11.4.2 Eurofins LifeCodexx GmbH Business Overview
11.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Introduction
11.4.4 Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.4.5 Eurofins LifeCodexx GmbH Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Introduction
11.5.4 Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.5.5 Illumina Recent Development
11.6 Laboratory Corporation of America
11.6.1 Laboratory Corporation of America Company Details
11.6.2 Laboratory Corporation of America Business Overview
11.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Introduction
11.6.4 Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.6.5 Laboratory Corporation of America Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Details
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Introduction
11.7.4 Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.7.5 Myriad Genetics Recent Development
11.8 Natera
11.8.1 Natera Company Details
11.8.2 Natera Business Overview
11.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Introduction
11.8.4 Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.8.5 Natera Recent Development
11.9 PerkinElmer Inc
11.9.1 PerkinElmer Inc Company Details
11.9.2 PerkinElmer Inc Business Overview
11.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Introduction
11.9.4 PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.9.5 PerkinElmer Inc Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Introduction
11.10.4 Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.10.5 Quest Diagnostics Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Introduction
11.11.4 Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
11.11.5 Sequenom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Trisomy Detection
Table 3. Key Players of Microdeletion Syndromes
Table 4. Key Players of Other
Table 5. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2026)
Table 9. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2027–2032)
Table 11. Microarray-based Non-Invasive Prenatal Testing Market Trends
Table 12. Microarray-based Non-Invasive Prenatal Testing Market Drivers
Table 13. Microarray-based Non-Invasive Prenatal Testing Market Challenges
Table 14. Microarray-based Non-Invasive Prenatal Testing Market Restraints
Table 15. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players (2021–2026)
Table 17. Global Top Microarray-based Non-Invasive Prenatal Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microarray-based Non-Invasive Prenatal Testing Revenue, 2025
Table 18. Ranking of Global Top Microarray-based Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Headquarters and Area Served
Table 21. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications
Table 22. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2021–2026)
Table 26. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2027–2032)
Table 28. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2021–2026)
Table 30. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2027–2032)
Table 32. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 47. Agilent Technologies Company Details
Table 48. Agilent Technologies Business Overview
Table 49. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product
Table 50. Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 51. Agilent Technologies Recent Development
Table 52. Ariosa Diagnostics (Roche) Company Details
Table 53. Ariosa Diagnostics (Roche) Business Overview
Table 54. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product
Table 55. Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 56. Ariosa Diagnostics (Roche) Recent Development
Table 57. BGI Group Company Details
Table 58. BGI Group Business Overview
Table 59. BGI Group Microarray-based Non-Invasive Prenatal Testing Product
Table 60. BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 61. BGI Group Recent Development
Table 62. Eurofins LifeCodexx GmbH Company Details
Table 63. Eurofins LifeCodexx GmbH Business Overview
Table 64. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product
Table 65. Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 66. Eurofins LifeCodexx GmbH Recent Development
Table 67. Illumina Company Details
Table 68. Illumina Business Overview
Table 69. Illumina Microarray-based Non-Invasive Prenatal Testing Product
Table 70. Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 71. Illumina Recent Development
Table 72. Laboratory Corporation of America Company Details
Table 73. Laboratory Corporation of America Business Overview
Table 74. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product
Table 75. Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 76. Laboratory Corporation of America Recent Development
Table 77. Myriad Genetics Company Details
Table 78. Myriad Genetics Business Overview
Table 79. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product
Table 80. Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 81. Myriad Genetics Recent Development
Table 82. Natera Company Details
Table 83. Natera Business Overview
Table 84. Natera Microarray-based Non-Invasive Prenatal Testing Product
Table 85. Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 86. Natera Recent Development
Table 87. PerkinElmer Inc Company Details
Table 88. PerkinElmer Inc Business Overview
Table 89. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product
Table 90. PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 91. PerkinElmer Inc Recent Development
Table 92. Quest Diagnostics Company Details
Table 93. Quest Diagnostics Business Overview
Table 94. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product
Table 95. Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 96. Quest Diagnostics Recent Development
Table 97. Sequenom Company Details
Table 98. Sequenom Business Overview
Table 99. Sequenom Microarray-based Non-Invasive Prenatal Testing Product
Table 100. Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 101. Sequenom Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture
Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type: 2025 vs 2032
Figure 4. Trisomy Detection Features
Figure 5. Microdeletion Syndromes Features
Figure 6. Other Features
Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application: 2025 vs 2032
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Independent Laboratories Case Studies
Figure 11. Microarray-based Non-Invasive Prenatal Testing Report Years Considered
Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Microarray-based Non-Invasive Prenatal Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2025 vs 2032
Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players in 2025
Figure 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025
Figure 18. North America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 20. United States Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 24. Germany Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2032)
Figure 32. China Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 40. Mexico Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 44. Israel Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Agilent Technologies Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 48. Ariosa Diagnostics (Roche) Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 49. BGI Group Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 50. Eurofins LifeCodexx GmbH Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 51. Illumina Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 52. Laboratory Corporation of America Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 53. Myriad Genetics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 54. Natera Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 55. PerkinElmer Inc Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 56. Quest Diagnostics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 57. Sequenom Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Trisomy Detection
Table 3. Key Players of Microdeletion Syndromes
Table 4. Key Players of Other
Table 5. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2026)
Table 9. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2027–2032)
Table 11. Microarray-based Non-Invasive Prenatal Testing Market Trends
Table 12. Microarray-based Non-Invasive Prenatal Testing Market Drivers
Table 13. Microarray-based Non-Invasive Prenatal Testing Market Challenges
Table 14. Microarray-based Non-Invasive Prenatal Testing Market Restraints
Table 15. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players (2021–2026)
Table 17. Global Top Microarray-based Non-Invasive Prenatal Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microarray-based Non-Invasive Prenatal Testing Revenue, 2025
Table 18. Ranking of Global Top Microarray-based Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Headquarters and Area Served
Table 21. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Products and Applications
Table 22. Global Key Players of Microarray-based Non-Invasive Prenatal Testing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2021–2026)
Table 26. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2027–2032)
Table 28. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2021–2026)
Table 30. Global Microarray-based Non-Invasive Prenatal Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2027–2032)
Table 32. North America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (US$ Million), 2027–2032
Table 47. Agilent Technologies Company Details
Table 48. Agilent Technologies Business Overview
Table 49. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product
Table 50. Agilent Technologies Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 51. Agilent Technologies Recent Development
Table 52. Ariosa Diagnostics (Roche) Company Details
Table 53. Ariosa Diagnostics (Roche) Business Overview
Table 54. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product
Table 55. Ariosa Diagnostics (Roche) Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 56. Ariosa Diagnostics (Roche) Recent Development
Table 57. BGI Group Company Details
Table 58. BGI Group Business Overview
Table 59. BGI Group Microarray-based Non-Invasive Prenatal Testing Product
Table 60. BGI Group Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 61. BGI Group Recent Development
Table 62. Eurofins LifeCodexx GmbH Company Details
Table 63. Eurofins LifeCodexx GmbH Business Overview
Table 64. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product
Table 65. Eurofins LifeCodexx GmbH Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 66. Eurofins LifeCodexx GmbH Recent Development
Table 67. Illumina Company Details
Table 68. Illumina Business Overview
Table 69. Illumina Microarray-based Non-Invasive Prenatal Testing Product
Table 70. Illumina Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 71. Illumina Recent Development
Table 72. Laboratory Corporation of America Company Details
Table 73. Laboratory Corporation of America Business Overview
Table 74. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product
Table 75. Laboratory Corporation of America Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 76. Laboratory Corporation of America Recent Development
Table 77. Myriad Genetics Company Details
Table 78. Myriad Genetics Business Overview
Table 79. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product
Table 80. Myriad Genetics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 81. Myriad Genetics Recent Development
Table 82. Natera Company Details
Table 83. Natera Business Overview
Table 84. Natera Microarray-based Non-Invasive Prenatal Testing Product
Table 85. Natera Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 86. Natera Recent Development
Table 87. PerkinElmer Inc Company Details
Table 88. PerkinElmer Inc Business Overview
Table 89. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product
Table 90. PerkinElmer Inc Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 91. PerkinElmer Inc Recent Development
Table 92. Quest Diagnostics Company Details
Table 93. Quest Diagnostics Business Overview
Table 94. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product
Table 95. Quest Diagnostics Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 96. Quest Diagnostics Recent Development
Table 97. Sequenom Company Details
Table 98. Sequenom Business Overview
Table 99. Sequenom Microarray-based Non-Invasive Prenatal Testing Product
Table 100. Sequenom Revenue in Microarray-based Non-Invasive Prenatal Testing Business (US$ Million), 2021–2026
Table 101. Sequenom Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Microarray-based Non-Invasive Prenatal Testing Picture
Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type: 2025 vs 2032
Figure 4. Trisomy Detection Features
Figure 5. Microdeletion Syndromes Features
Figure 6. Other Features
Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application: 2025 vs 2032
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Independent Laboratories Case Studies
Figure 11. Microarray-based Non-Invasive Prenatal Testing Report Years Considered
Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Microarray-based Non-Invasive Prenatal Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2025 vs 2032
Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players in 2025
Figure 16. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Microarray-based Non-Invasive Prenatal Testing Revenue in 2025
Figure 18. North America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 20. United States Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 24. Germany Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021–2032)
Figure 32. China Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 40. Mexico Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021–2032)
Figure 44. Israel Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Microarray-based Non-Invasive Prenatal Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Agilent Technologies Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 48. Ariosa Diagnostics (Roche) Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 49. BGI Group Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 50. Eurofins LifeCodexx GmbH Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 51. Illumina Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 52. Laboratory Corporation of America Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 53. Myriad Genetics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 54. Natera Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 55. PerkinElmer Inc Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 56. Quest Diagnostics Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 57. Sequenom Revenue Growth Rate in Microarray-based Non-Invasive Prenatal Testing Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232